Where do Krystal Biotech, Inc.'s ratios come from?

Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	41.4%+18.8pp	22.6%+245pp	-222.6%—	——
Net margin	52.6%+21.9pp	30.7%+9.1pp	21.6%—	——
EBITDA margin	42.9%+18.2pp	24.7%+239pp	-214.5%—	——
Free cash flow margin	48.5%+5.7pp	42.8%+241pp	-198.4%—	——
Returns
Return on equity	18.9%+8.6pp	10.3%+8.7pp	1.7%+26.8pp	-25.1%-9.4pp
Return on assets	17.1%+7.6pp	9.5%+7.9pp	1.6%+25.2pp	-23.6%-8.8pp
Return on invested capital	24%+12.2pp	11.9%+40.1pp	-28.3%+17.8pp	-46.1%+1.3pp
Efficiency
Asset turnover	0.3×0.0×	0.3×+0.2×	0.1×—	——
Liquidity
Current ratio	10×+2.7×	7.3×-10.5×	17.8×+4.5×	13.3×-3.9×
Quick ratio	9.6×+2.5×	7×-10.5×	17.6×+4.2×	13.3×-3.9×
Cash ratio	4.8×+1.4×	3.4×-7.4×	10.8×+5.2×	5.6×-7.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.9×+1.8×	-4.7×—	——	——
Interest coverage	5.7×+3.5×	2.2×—	——	——
Per Share
Book value per share	$40.72+28.0%	$31.82+13.4%	$28.06+37.0%	$20.49-23.4%
Valuation
Market capitalization	$7.15B+58.7%	$4.51B+28.9%	$3.49B+71.3%	$2.04B+17.1%
Enterprise value	$6.66B+59.8%	$4.17B+32.6%	$3.14B+66.7%	$1.89B+33.9%
Price / earnings	34.9×-15.6×	50.5×-269×	319.7×—	——
Price / sales	18.4×+2.9×	15.5×-53.4×	68.9×—	——
Price / book	5.9×+1.1×	4.8×+0.3×	4.5×+0.6×	3.9×+1.0×
EV / EBITDA	39.9×-18.3×	58.2×—	——	——
EV / sales	17.1×+2.8×	14.3×-47.7×	62×—	——
Free cash flow yield	2.6%-0.1pp	2.8%+5.6pp	-2.9%+4.6pp	-7.5%-0.9pp
Earnings yield	2.9%+0.9pp	2%+1.7pp	0.3%+7.2pp	-6.9%-2.9pp
PEG ratio	0.3×+0.2×	0.1×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Krystal Biotech, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Krystal Biotech, Inc.'s ratios come from?: Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.